| 前收盘价格 | 0.010 |
| 收盘价格 | 0.011 |
| 成交量 | 712,517 |
| 平均成交量 (3个月) | 2,994,250 |
| 市值 | 2,013,473 |
| 价格/销量 (P/S) | 0.270 |
| 股市价格/股市净资产 (P/B) | 5.98 |
| 52周波幅 | |
| 利润日期 | 29 Jul 2025 - 4 Aug 2025 |
| 营业毛利率 | -121.34% |
| 营业利益率 (TTM) | -120.31% |
| 稀释每股收益 (EPS TTM) | -0.040 |
| 季度收入增长率 (YOY) | 5.40% |
| 总债务/股东权益 (D/E MRQ) | 434.57% |
| 流动比率 (MRQ) | 0.870 |
| 营业现金流 (OCF TTM) | -3.09 M |
| 杠杆自由现金流 (LFCF TTM) | -2.28 M |
| 资产报酬率 (ROA TTM) | -56.81% |
| 股东权益报酬率 (ROE TTM) | -907.51% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (AU) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 看跌 | 看跌 | |
| 股票 | OSTEOPORE FPO [OSX] | - | - |
AIStockmoo 评分
0.5
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -1.0 |
| 平均 | 0.50 |
|
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Value |
| 内部持股比例 | 14.58% |
| 机构持股比例 | 7.16% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合